Test Directory
| Test Code | ||||
| U23DI | ||||
| Test Name | ||||
| 2,3-Dinor 11 Beta-Prostaglandin F2 Alpha | ||||
| CPT Codes | ||||
| 84150 | ||||
| Included Tests | ||||
|
||||
| Expected Turnaround Time | ||||
| 3 - 8 days | ||||
| Clinical Utility | ||||
| Screening for mast cell activation disorders including systemic mastocytosis using 24-hour urine specimens | ||||
| Specimen and Container Info | ||||
|
Specimen Type: 24 Hour Urine
Collection Container: 24 Hour Plastic Urine Container
Desired Specimen Volume: 5 mL |
||||
| Collection Instructions | ||||
|
||||
| Processing and Submission Instructions | ||||
|
||||
| Patient Preparation | ||||
|
Patients taking aspirin or nonsteroidal anti-inflammatory drugs (NSAIDs) may have decreased concentrations of prostaglandin F2 alpha. If medically feasible, for 2 weeks before specimen collection, patient should not take aspirin and for 72 hours before specimen collection, patient should not take NSAIDs. |
||||
| Transport Instructions | ||||
|
Transport to the laboratory refrigerated. |
||||
| Stability Requirements | ||||
|
||||
| Methodology | ||||
| Varies By Test | ||||
| Reference Intervals | ||||
|
See patient report. |
||||
| Limitations | ||||
|
Elevated levels of 2,3-dinor-11beta-prostaglandin F2 alpha (2,3 BPG) in urine are not specific for systemic mast cell disease and may be found in patients with angioedema, diffuse urticaria, or myeloproliferative diseases in the absence of diffuse mast cell proliferation. Systemic mast cell disease is a heterogeneous disease, and some patients may not have elevated 2,3 BPG in urine. Patients taking aspirin or non-steroidal anti-inflammatory drugs (NSAIDs) may have decreased concentrations of prostaglandin F2 alpha if dosage has not been discontinued for 2 weeks or 72 hours, respectively. |
||||
| Alternate Names | ||||
|
||||
| Reference Lab | ||||
| Mayo Clinic Laboratories | ||||
| Testing Schedule | ||||
| Routine, 2 times per week | ||||
The American Medical Association (AMA) Current Procedural Terminology (CPT) codes published by HNL Lab Medicine are guidelines and are intended for informational purposes only. CPT coding is the exclusive responsibility of the billing entity. View the Terms.
© 2026 HNL Lab Medicine. All rights reserved.